Logo

Crossref


1. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease

- Cheryl Huang

- Jun Jie Seah

- Chin Kimg Tan

- Jia Wen Kam

- Jessica Tan

- Eng Kiong Teo

- Andrew Kwek

- Yu Jun Wong

- Malcolm Tan

- Tiing Leong Ang

- Rahul Kumar

2. Novel scores combining AFP with non‐invasive markers for prediction of liver fibrosis in chronic hepatitis C patients

- Mohamed Gamil

- Mohamed Alboraie

- Mohammad El‐Sayed

- Aisha Elsharkawy

- Noha Asem

- Tamer Elbaz

- Mohammad Mohey

- Bahaa Abbas

- Mai Mehrez

- Gamal Esmat

3. Pathology Predictors of Response to Combined Therapy of Chronic HCV Patients; Is it Applicable in the DAA Era?

- Samar Kamal Darweesh

4. Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals

- Rabab Fouad

- Aisha Elsharkawy

- Shereen Abdel Alem

- Mohamed El Kassas

- Mohamed Alboraie

- Ahmad Sweedy

- Shimaa Afify

- Zeinab Abdellatif

- Marwa Khairy

- Gamal Esmat

5. Comparing the efficiency of Fib‐4, Egy‐score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C

- Ahmed Cordie

- Ahmed Salama

- Marwa El‐Sharkawy

- Saeed M. El‐Nahaas

- Marwa Khairy

- Aisha Elsharkawy

- Mohamed Hassany

- Gamal Esmat

6. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study

- Mohamed Said

- Zeinab Soliman

- Hosam Daebes

- Saeed M El-Nahaas

- Magdy El-Serafy

7. Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore

- Yue Zhao

- Prem Harichander Thurairajah

- Rahul Kumar

- Jessica Tan

- Eng Kiong Teo

- John Chen Hsiang

8. Derivation of “Egyptian varices prediction (EVP) index”: A novel noninvasive index for diagnosing esophageal varices in HCV Patients

- Shimaa M. Abd-Elsalam

- Mohamed M. Ezz

- Shehab Gamalel-Din

- Gamal Esmat

- Wafaa Elakel

- Mahmoud ElHefnawi

9. Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C

- Masaya Saito

- Yoshihiko Yano

- Hirotaka Hirano

- Kenji Momose

- Masaru Yoshida

- Takeshi Azuma

10. Data Mining and Machine Learning Algorithms Using <i>IL28B</i> Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C

- Hend Ibrahim Shousha

- Abubakr Hussein Awad

- Dalia Abdelhamid Omran

- Mayada Mohamed Elnegouly

- Mahasen Mabrouk

11. Changes in serum interferon-γ-inducible protein-10 levels and liver stiffness among chronic hepatitis C Egyptian patients in response to directly acting antiviral agents

- Saeed M. El-Nahaas

- Normeen Hany Rady

- Shimaa Malek

- Khaled Serag

12. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study

- Ahmed Hashem

- Abubakr Awad

- Hend Shousha

- Wafaa Alakel

- Ahmed Salama

- Tahany Awad

- Mahasen Mabrouk

13. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV‐genotype 4 in Egypt

- P. Bonnard

- A. Elsharkawy

- K. Zalata

- E. Delarocque‐Astagneau

- L. Biard

- L. Le Fouler

- A. B. Hassan

- M. Abdel‐Hamid

- M. El‐Daly

- M. E. Gamal

- M. El Kassas

- P. Bedossa

- F. Carrat

- A. Fontanet

- G. Esmat

14. The Efficacy of aHansenula-Derived 20 kDa Pegylated Interferon Alpha-2a in the Treatment of Genotype 4 Chronic Hepatitis C

- Hany Shehab

- Tamer Elbaz

- Dalia Deraz

- Amal Hafez

- Inas Elattar

15. Liver Biopsy Versus Non-Invasive Tests in Determining Liver Disease Status

- Seyed Moayed Alavian

16. Comparative study between liver biopsy and non-invasive biomarkers in assessment of hepatic fibrosis in children with chronic liver diseases

- Ola Galal Behairy

- Ola Samir El-Shimi

- Naglaa Hamed Shalan

17. Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients

- Hend Ibrahim Shousha

- Yasmin Saad

- Doa’a A. Saleh

- Hosam Dabes

- Magdy Alserafy

- Yehia ElShazly

- Mohamed Said

18. Value of Egy‐Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase‐to‐platelet ratio index, FIB‐4 and Forns' index in chronic hepatitis C virus

- Mohamed Alboraie

- Marwa Khairy

- Marwa Elsharkawy

- Noha Asem

- Aisha Elsharkawy

- Gamal Esmat

19. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients

- Chia-Chi Wang

- Chen-Hua Liu

- Chih-Lin Lin

- Pin-Chao Wang

- Tai-Chung Tseng

- Hans Hsienhong Lin

- Jia-Horng Kao

20. The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis

- Marwa Khairy

- Rabab Fouad

- Mahassen Mabrouk

- Wafaa El-Akel

- Abu Bakr Awad

- Rabab Salama

- Mayada Elnegouly

- Olfat Shaker

21. Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania

- Camelia Sultana

- Simona Manuela Erscoiu

- Camelia Grancea

- Emanoil Ceausu

- Simona Ruta

22. Performance of machine learning approaches on prediction of esophageal varices for Egyptian chronic hepatitis C patients

- Shimaa M. Abd El-Salam

- Mohamed M. Ezz

- Somaya Hashem

- Wafaa Elakel

- Rabab Salama

- Hesham ElMakhzangy

- Mahmoud ElHefnawi